Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study
CONCLUSIONS: Our study showed that a delay in belimumab initiation led to higher SLEDAI-2K score and difficulty in achieving a 50% GC reduction at 96 weeks. Since GC-related adverse events increase with long-term administration of GC though with small daily doses, we proposed here that belimumab should be started in combination with higher daily prednisolone.PMID:38509864 | DOI:10.1177/09612033241240859
Source: Lupus - Category: Rheumatology Authors: Takashi Yamane Akira Hashiramoto Source Type: research
More News: Hydroxychloroquine | Lupus | Nephritis | Prednisolone | Rheumatology | Statistics | Study